Neurologic Solutions Granted FDA 510K Clearance for its Seizure Onset Zone Detection Software Awarded a Phase I Small Business Innovation Research Grant from the National Science Foundation
BALTIMORE, Md. (May 13th, 2021)—Neurologic Solutions, Inc. announced today that it received the National Science Foundation SBIR Phase I grant